Rolf M. Zinkernagel
Fondatore presso Hookipa Biotech AG
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Hans Jörg Reinhardt | M | 68 | 40 anni | |
Bill Winters | M | 62 | 11 anni | |
Vasant Narasimhan | M | 48 | 19 anni | |
Charles Sawyers | M | 65 | 11 anni | |
Samir Shah | M | 63 | 20 anni | |
Charlotte Pamer-Wieser | M | - | 13 anni | |
Heidi Feik | F | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Vera Strasser | F | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Franz Heinz | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Arnaud Marchant | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Gregor Zünd | M | 65 |
University of Zurich
| 20 anni |
Lukas Flatz | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 13 anni |
Andreas Bergthaler | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 13 anni |
Paul-Henri Lambert | M | 85 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Harry Werner Kirsch | M | 59 | 21 anni | |
Frank Kalkbrenner | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 11 anni |
Daniel D. Pinschewer | M | 49 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 13 anni |
Michael Kelly | M | 67 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 5 anni |
Urs F. Greber | M | - |
University of Zurich
| 21 anni |
Hans Peter Wehrli | M | 72 |
University of Zurich
| 31 anni |
Graziano Seghezzi | M | 55 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Hans Caspar von der Crone | M | 67 |
University of Zurich
| 27 anni |
Sander J. van Deventer | M | 69 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Graeme Martin | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Linda Armstrong | M | 61 | 17 anni | |
Markus Hosang | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | - |
Andreas Plückthun | M | 65 |
University of Zurich
| 31 anni |
Jan van de Winkel | M | 63 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 7 anni |
Jörn Aldag | M | 65 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 8 anni |
Simon Brown | M | - | 11 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Joseph Jimenez | M | 64 | 11 anni | |
Ulrich Lehner | M | 78 | 13 anni | |
Wendelin Wiedeking | M | 72 | 11 anni | |
Ronen Tamir | M | 57 | - | |
Giancarlo Mocchi | M | 84 | 3 anni | |
Gary Sutton | M | - | 13 anni | |
Dimitri Azar | M | 65 | 7 anni | |
Juan Andres | M | 59 | 12 anni | |
Kim Stratton | F | 62 | 3 anni | |
Enrico Cipro Vanni | M | 73 | - | |
Alexander Tobler | M | - |
University of Zurich
| 6 anni |
Teodoro D. Cocca | M | 52 |
University of Zurich
| 7 anni |
Dirk van de Put | M | 63 | 1 anni | |
Katherine Cohen | M | - |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | 5 anni |
Daniel Anders | M | 54 |
University of Zurich
| 7 anni |
Judith Bischof | M | 50 |
University of Zurich
| 6 anni |
Verena A. Briner | M | 72 | 3 anni | |
Iris Bohnet Zürcher | M | 58 |
University of Zurich
| 5 anni |
Peter Maag | M | 57 | 5 anni | |
Thomas Meier | M | - |
University of Zurich
| 6 anni |
Oliver Hofmann | M | 53 |
University of Zurich
| 6 anni |
Philippe Bertschi | M | - |
University of Zurich
| 6 anni |
Philippe Weber | M | 59 |
University of Zurich
| 5 anni |
David Schmid | M | 42 |
University of Zurich
| 5 anni |
Michel Fellmann | M | - |
University of Zurich
| 6 anni |
Mariel Hoch | M | 51 |
University of Zurich
| 14 anni |
Rene Dittrich | M | 52 |
University of Zurich
| 6 anni |
Georgette Schmid | F | - |
University of Zurich
| 6 anni |
Marc Weber | M | 53 |
University of Zurich
| 7 anni |
Simon Lamprecht | M | 51 |
University of Zurich
| 3 anni |
Susanne Antonie Schaffert | M | 57 | 2 anni | |
Sandra Nadine Ramsauer | M | - |
University of Zurich
| 14 anni |
Thomas Wellauer | M | 69 | - | |
Mun Tak Yang | F | 70 | - | |
Ann Marie Fudge | F | 72 | - | |
William Brody | M | 80 | - | |
Daniel Vasella | M | 70 | 17 anni | |
Alexandre F. Jetzer-Chung | M | 83 | 15 anni | |
Srikant T. Madhav Datar | M | 70 | 18 anni | |
Jürgen Brokatzky-Geiger | M | 72 | 14 anni | |
Daniel Schmucki | M | 56 |
University of Zurich
| 6 anni |
Thomas Roland Meier | M | 61 |
University of Zurich
| 4 anni |
Andreas von Planta | M | 69 | - | |
Dominik Escher | M | - |
University of Zurich
| 8 anni |
Reto Suter | M | 53 |
University of Zurich
| 8 anni |
Michael Sidler | M | 56 |
University of Zurich
| 8 anni |
Shannon Klinger | M | 53 | 10 anni | |
Cédric Perlet | M | - |
University of Zurich
| 7 anni |
Vic Myer | M | - | 11 anni | |
Gina Massa Mias | F | - | - | |
Ramon Mohanlal | M | 65 | 3 anni | |
Muriel Cottard | M | - | 14 anni | |
George Gunn | M | 74 | 12 anni | |
Kleem Chaudhary | M | 48 | 7 anni | |
Sanjay Shukla | M | 52 | 3 anni | |
Frank Palantoni | M | 66 | 6 anni | |
Fredrik Ollila | M | - | - | |
Sierk Poetting | M | 51 | 2 anni | |
Johannes Suter | M | - |
University of Zurich
| 5 anni |
Ian Garland | M | 59 | - | |
Ueli Roost | M | 76 |
University of Basel
| 4 anni |
Mihael Polymeropoulos | M | 64 | 5 anni | |
Adrian Widmer | M | 56 |
University of Zurich
| 6 anni |
Rudolf Marty | M | 75 |
University of Zurich
| 10 anni |
Atul Khosia | M | - | - | |
Paolo Baroldi | M | 73 | 4 anni | |
Brian McNamara | M | 57 | - | |
Lijin Aryananda | M | - |
University of Zurich
| 4 anni |
Anne-Françoise Viollier | M | - |
University of Basel
| 4 anni |
Hans Ulrich Maerki | M | 76 |
University of Basel
| 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Svizzera | 83 | 83.00% |
Austria | 17 | 17.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Rolf M. Zinkernagel
- Contatti personali